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The true prevalence of gestational diabetes mellitus (GDM) is unknown. The objective of this study was 1) to provide 
the most current GDM prevalence reported on the birth certificate and the Pregnancy Risk Assessment Monitoring 
System (PRAMS) questionnaire and 2) to compare GDM prevalence from PRAMS across 2007–2008 and 2009–2010.
Methods
We examined 2010 GDM prevalence reported on birth certificate or PRAMS questionnaire and concordance between 
the sources. We included 16 states that adopted the 2003 revised birth certificate. We also examined trends from 2007 
through 2010 and included 21 states that participated in PRAMS for all 4 years. We combined GDM prevalence across 
2-year intervals and conducted t tests to examine differences. Data were weighted to represent all women delivering 
live births in each state.
Results
GDM prevalence in 2010 was 4.6% as reported on the birth certificate, 8.7% as reported on the PRAMS questionnaire, 
and 9.2% as reported on either the birth certificate or questionnaire. The agreement between sources was 94.1% 
(percent positive agreement = 3.7%, percent negative agreement = 90.4%). There was no significant difference in GDM 
prevalence between 2007–2008 (8.1%) and 2009–2010 (8.5%, P = .15).
Conclusion
Our results indicate that GDM prevalence is as high as 9.2% and is more likely to be reported on the PRAMS 
questionnaire than the birth certificate. We found no statistical difference in GDM prevalence between the 2 phases. 
Further studies are needed to understand discrepancies in reporting GDM by data source.
Introduction
Gestational diabetes mellitus (GDM) is defined as impaired glucose tolerance with onset or first recognition during 
pregnancy (1). Women with GDM are at high risk for pregnancy and delivery complications including infant 
macrosomia, neonatal hypoglycemia, and cesarean delivery (2,3). Additionally, women who are affected by GDM have 
more than a 7-fold increased risk of developing type 2 diabetes 5 to 10 years after delivery (4). Children born to 
mothers with GDM are also more likely to develop impaired glucose tolerance (5). Risk factors for GDM include higher 
parity, advanced maternal age, family history of diabetes mellitus, nonwhite race, and overweight and obesity (6–8).
Although the true prevalence of GDM is unknown, GDM is estimated to affect 1% to 14% of pregnancies in the United 
States annually, depending on the population studied and the diagnostic tests used (9–11). GDM prevalence has been 
steadily increasing with the rise of obesity and type 2 diabetes (12). Both birth certificates and the Pregnancy Risk 
Assessment Monitoring System (PRAMS), which includes a questionnaire completed by mothers, can provide 
population-based prevalence estimates of GDM. However, birth certificate data are limited in that in 2010, only 33 
states and the District of Columbia, representing 76% of all 2010 births in the United States, had implemented the 
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2003 revised birth certificate, which differentiates pre-pregnancy diabetes from GDM (13). Moreover, studies indicate 
that whereas specificity for GDM is high on the birth certificate, sensitivity is as low as 48% (14). Thus, GDM 
prevalence obtained from the birth certificate alone is likely underestimated. In contrast, PRAMS may overestimate 
GDM prevalence. CDC periodically updates its PRAMS questions to reflect evidence-based revisions, with each revised 
version constituting a new phase. In a validation study of the PRAMS phase 5 (2007–2008) GDM question across 5 
states, 61.8% of 277 study participants who reported GDM on the questionnaire did not have a GDM diagnosis in their 
prenatal or hospital medical records (15). In an attempt to reduce misclassification of GDM diagnosis based on 
maternal self-report, PRAMS revised the GDM question for phase 6 (15,16). On the basis of this PRAMS phase 5 
validation study, which found that the PRAMS question substantially overestimated the GDM prevalence, we 
hypothesized that the change in the GDM question would result in a lower prevalence of GDM.
The objective of this analysis was 1) to provide a current estimate of GDM prevalence among PRAMS states using the 




We analyzed 2007–2010 data from PRAMS, an ongoing, state-based, population-based surveillance system that 
collects information about maternal behaviors before, during, and after pregnancies that result in live births. Using 
birth certificates, PRAMS researchers sample live births delivered within the previous 2 to 4 months. Self-
administered questionnaires are mailed to mothers’ homes; nonresponders are followed up by telephone. Each 
questionnaire is linked to the respondent’s child’s birth certificate. More details on PRAMS are available at 
www.cdc.gov/prams.
GDM was ascertained from both the birth certificate and the PRAMS questionnaire. We defined GDM as present if it 
was reported on either data source and the woman did not report a diagnosis of prepregnancy diabetes on the 
questionnaire. The birth certificate variable is based on a check box that differentiates prepregnancy diabetes 
(diagnosis before this pregnancy) from gestational diabetes (diagnosis in this pregnancy). During PRAMS phase 5 
(2005–2008), women were asked to select from a list any problems they had during their most recent pregnancy, 
including “high blood sugar (diabetes) that started during this pregnancy.” Beginning in 2009 (PRAMS phase 6), 
women were asked, “During your most recent pregnancy, were you told by a doctor, nurse, or other health care worker 
that you had gestational diabetes (diabetes that started during this pregnancy)?” Women who responded yes to either 
question were considered to have GDM for the respective survey.
For both PRAMS phase 5 and phase 6, we obtained data from the birth certificate on maternal race/ethnicity; 
education; marital status; parity; enrollment in the Special Supplemental Nutrition Program for Women, Infants, and 
Children (WIC); and Medicaid. Maternal race/ethnicity was characterized as non-Hispanic white, non-Hispanic black, 
Hispanic, American Indian/Alaskan Native, Asian/Pacific Islander, and other. On the 2003 birth certificate, 
respondents were able to select Hispanic ethnicity and a separate race category. We categorized anyone who reported 
Hispanic ethnicity as Hispanic, regardless of any secondary race classification. We categorized Chinese, Japanese, 
Filipino, Hawaiian, and “Other Asian” as Asian/Pacific Islander. “Other” includes those who reported mixed race or 
any race/ethnicity other than those described above. The state of Vermont released their race/ethnicity data only as 
non-Hispanic white or “other.”
Maternal education was characterized as less than 12 years, 12 years, or 13 or more years, depending on the highest 
level of school completed. Marital status was characterized as married (at birth, conception, or any time between) or 
other. Parity was characterized as 0, 1, or 2 or more. We used Medicaid and WIC enrollment as proxy indicators of 
socioeconomic status.
Statistical analysis
We examined demographic factors, including maternal age, race/ethnicity, parity, maternal education, marital status, 
WIC enrollment, and Medicaid, overall and by GDM prevalence for 2010. We used χ tests to examine differences in 
GDM prevalence by demographics. We then calculated the 2010 prevalence overall and by geographic area according 
to reporting sources. Furthermore, we examined concordance between the 2 sources by calculating the percent 
agreement.
We combined estimated GDM prevalence across 2-year intervals in PRAMS phase 5 (2007–2008) and phase 6 (2009–
2010) and then conducted t tests to examine whether there were differences in the prevalence of GDM as reported by 
the different questionnaires.
States were included in our GDM prevalence estimates if they had adopted the 2003 revised birth certificate and met 
the 65% response rate threshold for the PRAMS questionnaire in 2010. Fifteen states and New York City met these 
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criteria. Twenty-one states were included in our comparison of phase 5 and phase 6 PRAMS questionnaires because 
they met the 65% response threshold for the PRAMS questionnaire for 2007–2010.
PRAMS data are weighted to represent all women delivering live births within each state, adjusting for sampling 
design, noncoverage, and nonresponse. We used SAS-callable SUDAAN 10.0.1 (Research Triangle Park, North 
Carolina) for all statistical analyses. We assessed significance at P < .05.
Results
2010 Prevalence estimates of GDM
Records from 23,479 women in 2010, representing 1,353,810 births, were included in our analysis. In 2010, PRAMS 
survey participants were predominantly non-Hispanic white, having their first child, married, had more than a high 
school education, and were not enrolled in WIC or Medicaid (Table 1). GDM prevalence increased with maternal age, 
number of children, and WIC use, and decreased with higher education. Prevalence varied by maternal race/ethnicity; 
Asian/Pacific Islanders and Hispanics had the highest prevalence estimates (16.3% and 12.1%, respectively). Non-
Hispanic whites had the lowest prevalence estimate (6.8%). GDM prevalence by maternal characteristic using the birth 
certificate only and the PRAMS questionnaire only showed similar results.
The prevalence of GDM was 9.2% in 2010 among the 15 states and New York City when either the birth certificate or 
the PRAMS questionnaire indicated a GDM diagnosis (Table 2). The prevalence from the birth certificate alone was 
4.6% and the prevalence from the PRAMS questionnaire alone was 8.7%. The percent agreement between the birth 
certificate and questionnaire was 94.1%. The percent positive agreement was 3.7% and the percent negative agreement 
was 90.4%. Overall, 5% of mothers who self-reported GDM diagnosis on the questionnaire did not have GDM recorded 
on the birth certificate and 0.9% of mothers who had GDM reported on their birth certificate did not self-report a GDM 
diagnosis on the questionnaire. Across both data sources, Wyoming had the lowest GDM prevalence (range, 2.2%–
5.5%) and New York City had the highest prevalence (range, 5.4%–11.7%) (Table 2).
GDM estimates from PRAMS phase 5 and phase 6
Records from 123,373 women from 2007–2010, representing 4,223,575 births, were included in our analysis. In the 21 
states that participated in both phases, there was no significant difference between the GDM prevalence from the 
phase 5 PRAMS questionnaire (8.1%) and the prevalence from the phase 6 questionnaire (8.5%) (P = .15) (Table 3). 
There was also no significant difference between the GDM prevalence from PRAMS phase 5 and phase 6 in any of the 
21 states. In both phases, Utah had the lowest prevalence (5.7% in phase 5 and 5.6% in phase 6) and Rhode Island had 
the highest prevalence (10.4% in phase 5 and 11.7% in phase 6).
Discussion
Our data suggests that the prevalence of GDM in 2010 was between 4.6% (as reported on the birth certificate only) and 
9.2% (as reported on either the birth certificate or PRAMS questionnaire). Although there was high agreement (94.1%) 
between the 2 sources, more cases of GDM are identified through the PRAMS questionnaire than from the birth 
certificate. In our analysis, 5% of mothers who self-reported GDM diagnosis on the questionnaire in 2010 did not have 
GDM recorded on the birth certificate. Birth certificate data have been shown to underestimate GDM prevalence. In a 
comprehensive literature review summarizing the validity of birth certificate data for identifying diabetes-complicated 
births, the sensitivity for identifying GDM ranged from 46% to 83%, with a median of 65%; specificity was consistently 
above 98% (14).
In PRAMS phase 5, women were asked if they had high blood glucose during this pregnancy. Because GDM diagnosis 
is based on a 2-step test where women who have positive results on the first glucose challenge test go on to an oral 
glucose tolerance test, only women who have positive results on both tests would be diagnosed with GDM. Some 
women who had positive results on the first test but not the second may respond that they had high blood glucose in 
this pregnancy. In PRAMS phase 6, the wording of the question was changed so that mothers were asked if they were 
told by a clinician they specifically had “gestational diabetes” instead of “high blood sugar.” We hypothesized that this 
wording change would reduce misclassification and result in a lower GDM prevalence in phase 6 compared with phase 
5. However, we found no significant difference in GDM prevalence between the 2 phases. We do not know if this is 
evidence that the phase 6 question continues to overestimate true GDM prevalence or if it reflects a true increase in 
GDM prevalence. However, a recent study of 100 women in Utah who reported GDM on the phase 6 questionnaire but 
had no indication of GDM on their child’s birth certificate reported that 42% of these women did not have a GDM 
diagnosis in their medical records (15). Therefore, given the current limitations of both the birth certificate and 
PRAMS, true GDM prevalence is likely between the estimates obtained from the 2 sources.
An additional challenge in determining GDM prevalence is that prevalence is very sensitive to the diagnostic criteria 
used. In recent years criteria have changed and there has been a lack of consensus about which criteria to use (17). The 
3 primary criteria used in the United States are by the National Diabetes Data Group (18), Carpenter and Coustan (19), 
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and the International Association of Diabetes and Pregnancy Study Groups (IADPSG) (20). The first 2 criteria are 
recommended by the American Congress of Obstetricians and Gynecologists (ACOG) and result in a GDM diagnosis in 
about 5% to 6% of pregnancies, whereas the latter is recommended by the American Diabetes Association (1) and 
results in a GDM diagnosis in about 18% to 20% of pregnancies (21). Recently, the National Institutes of Health 
Consensus Development Conference concluded that “there is not sufficient evidence to adopt . . .the IADPSG 
[diagnostic criteria]” (21). During our study period it is likely that a mix of these criteria was used, but neither the birth 
certificate nor PRAMS ascertains which criteria were used for GDM diagnoses. Further studies are needed to identify 
which criteria are most commonly used by physicians.
Even if our most conservative estimate is used, GDM still affects nearly 1 in 20 (4.6%) pregnancies in the United 
States, meaning a substantial number of women are at greater risk for obstetric complications (2) and for developing 
type 2 diabetes later in life (4). The children born to these mothers are also more likely to develop impaired glucose 
tolerance and metabolic complications (22). In addition, Chen and colleagues found that GDM increased US medical 
costs by $636 million in 2007 (10). Moreover, approximately 36% of GDM-related medical costs are covered by 
government programs, primarily Medicaid (10).
A recent study showed that GDM rates differ by state, with the greatest variation attributable to differences in obesity 
(23). Obesity is known to be associated with GDM (24); nearly 50% of GDM could potentially be prevented if we 
reduced the risk of overweight and obesity to that of normal-weight women (25). Preventing obesity is a key 
component of well woman care, regardless of pregnancy intentions. Since half of US pregnancies are unintended (26), 
maintaining a healthy weight throughout the reproductive years benefits women and improves the health of any future 
pregnancies. Emphasis should be placed on ensuring access to weight management counseling and treatment as a 
standard component of routine care, particularly among high-risk groups. Both the Centers for Disease Control and 
Prevention (CDC) and ACOG recommend well woman care, including obesity screening (27,28). Counseling about 
nutrition and physical activity, as well as appropriate contraceptive use, may help women achieve a healthy weight 
before pregnancy. However, lack of providers offering this kind of care, public awareness to seek well woman services, 
and insurance coverage of those services represent significant barriers to access (28,29).
This analysis includes a few limitations. Our 2010 GDM prevalence estimate is limited to those states that adopted the 
2003 revised birth certificate and provided PRAMS data. The 15 states and New York City included in our analysis 
represent approximately one-third of births in 2010 and therefore may not be representative of the entire United 
States. Additionally, the respondents included in this study may differ from those who were excluded. PRAMS excludes 
women who had stillbirths or fetal deaths, which may be associated with gestational diabetes (30). Finally, our 
estimates are based on administrative and self-report data and are therefore subject to reporting biases.
The true prevalence of GDM is unknown, and estimates rely on data sources that all have limitations. Our analysis 
adds 2 additional data points to the literature for population-based prevalence estimates of GDM for 2010 and also 
shows how the data sources — the birth certificate and mothers’ self-report on the PRAMS questionnaire — relate to 
one another. The true prevalence of GDM likely lies between our prevalence estimates of 4.6% and 9.2%. Our results 
indicate that GDM prevalence is high in the United States, and we found no evidence of change between 2007 and 
2010. However, there is a need for understanding the discrepancies in GDM prevalence estimates by data sources and 
for a consensus on which diagnostic criteria to use. GDM is a significant public health concern because of its long-term 
implications for maternal and child health. This study provides additional information about prevalence of GDM, 
which is important for understanding the future burden of related diseases, most notably type 2 diabetes, and related 
health care costs.
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Tables
Table 1. Maternal Characteristics and GDM Prevalence For 15 States and 
New York City, Pregnancy Risk Assessment Monitoring System (PRAMS) 
2010
Characteristic
Sample with Maternal Characteristic, % 
(SE)
GDM by Maternal Characteristic, % 
(SE)
Maternal age, y
<20 9.6 (0.4) 6.0 (1.1)
20–24 23.0 (0.5) 5.9 (0.6)
25–29 28.8 (0.5) 8.2 (0.6)
30–34 24.3 (0.5) 11.1 (0.8)
≥35 14.3 (0.4) 15.5 (1.2)
Maternal race-ethnicity
Non-Hispanic white 52.8 (0.4) 6.8 (0.4)
Non-Hispanic black 13.9 (0.3) 10.5 (0.9)
Hispanic 25.9 (0.3) 12.1 (0.9)
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Characteristic
Sample with Maternal Characteristic, % 
(SE)




Asian/Pacific Islander 4.3 (0.2) 16.3 (1.8)
Other 2.5 (0.2) 10.0 (2.4)
Parity
0 40.5 (0.6) 7.8 (0.5)
1 31.0 (0.6) 9.0 (0.7)
≥2 28.5 (0.6) 11.4 (0.8)
Maternal education, y
<12 20.0 (0.5) 12.3 (1.0)
12 25.0 (0.5) 9.4 (0.8)
≥13 55.0 (0.6) 7.9 (0.4)
Marital status
Married 60.2 (0.6) 9.1 (0.4)
Other 39.8 (0.6) 9.3 (0.6)
WIC enrolled
Yes 49.2 (0.6) 10.8 (0.6)
No 50.8 (0.6) 7.6 (0.4)
Health insurance
Medicaid 43.2 (0.6) 9.9 (0.5)
Other 56.8 (0.6) 8.7 (0.5)
Abbreviations: GDM, gestational diabetes mellitus; SE, standard error; WIC, Special Supplemental Nutrition Program for 
Women, Infants, and Children.
States and metropolitan areas included were Colorado, Delaware, Georgia, Maryland, Missouri, Nebraska, New York, New 
York City, Ohio, Oklahoma, Oregon, Texas, Utah, Vermont, Washington, and Wyoming.
GDM prevalence estimates were calculated for women who had GDM reported either on the birth certificate or PRAMS 
questionnaire but did not self-report pre-pregnancy diabetes.
Difference in prevalence of GDM by maternal characteristic (P < .05) by χ test.
Table 2. Comparison of GDM Prevalence by Data Source, 15 States and New 







Both BC and PRAMS 
Questionnaire, % (SE)
Either BC or PRAMS 
Questionnaire, % (SE)
Total 4.6 (0.3) 8.7 (0.3) 3.7 (0.2) 9.2 (0.4)
Colorado 4.7 (0.7) 6.1 (0.8) 3.7 (0.6) 7.1 (0.8)
Delaware 3.5 (0.6) 8.3 (0.8) 3.1 (0.5) 8.3 (0.8)
Georgia 4.6 (1.1) 7.8 (1.3) 3.2 (0.9) 8.9 (1.4)
Maryland 3.9 (0.7) 8.5 (1.1) 3.2 (0.6) 8.9 (1.1)
Missouri 5.3 (0.7) 7.0 (0.8) 3.7 (0.5) 8.2 (0.8)
Nebraska 4.4 (0.6) 9.4 (0.8) 3.5 (0.5) 9.9 (0.8)















Both BC and PRAMS 
Questionnaire, % (SE)
Either BC or PRAMS 
Questionnaire, % (SE)
New York City 6.2 (0.8) 11.5 (1.1) 5.4 (0.8) 11.7 (1.1)
Ohio 4.8 (0.8) 8.3 (1.0) 4.2 (0.7) 9.0 (1.1)
Oklahoma 3.1 (0.7) 8.2 (1.0) 2.0 (0.5) 8.6 (1.1)
Oregon 6.4 (0.8) 10.4 (1.0) 5.1 (0.7) 11.0 (1.0)
Texas 4.0 (0.6) 10.0 (0.9) 3.3 (0.6) 10.3 (0.9)
Utah 4.0 (0.5) 6.4 (0.7) 3.5 (0.5) 6.6 (0.7)
Vermont 4.2 (0.6) 6.9 (0.8) 3.9 (0.6) 7.0 (0.8)
Washington 5.0 (0.6) 8.8 (0.8) 4.0 (0.6) 9.3 (0.9)
Wyoming 3.0 (0.6) 4.8 (0.7) 2.2 (0.5) 5.5 (0.7)
Abbreviations: GDM, gestational diabetes mellitus; BC, birth certificate; SE, standard error.
Table 3. Prevalence of GDM by State From Pregnancy Risk Assessment 
Monitoring System (PRAMS) Questionnaires, 2007–2010
State or 
Metropolitan Area
GDM Prevalence from PRAMS Phase 
5, 2007–2008, % (SE)
GDM Prevalence from PRAMS Phase 
6, 2009–2010, % (SE)
P
Value
Total 8.1 (0.2) 8.5 (0.2) .15
Alaska 7.8 (0.7) 7.7 (0.7) .93
Arkansas 9.2 (0.7) 10.0 (0.8) .46
Colorado 5.9 (0.5) 6.8 (0.6) .22
Delaware 8.1 (0.6) 7.7 (0.6) .69
Georgia 7.6 (1.0) 8.8 (1.0) .42
Hawaii 10.2 (0.5) 11.3 (0.7) .24
Maine 9.2 (0.7) 9.4 (0.7) .83
Maryland 8.4 (0.7) 8.9 (0.8) .59
Massachusetts 6.9 (0.6) 6.5 (0.6) .62
Minnesota 7.7 (0.5) 7.9 (0.6) .80
Nebraska 8.1 (0.6) 8.9 (0.6) .28
New Jersey 9.9 (0.6) 9.1 (0.6) .31
Ohio 8.3 (0.7) 9.3 (0.8) .36
Oklahoma 9.2 (0.8) 7.8 (0.7) .18
Oregon 9.2 (0.8) 10.1 (0.7) .39
Rhode Island 10.4 (0.7) 11.7 (0.8) .22
Utah 5.7 (0.4) 5.6 (0.4) .98
Vermont 6.1 (0.5) 6.5 (0.5) .60
Washington 8.2 (0.6) 9.2 (0.6) .24
West Virginia 9.0 (0.7) 10.1 (0.7) .25
Wyoming 6.0 (0.6) 5.6 (0.6) .63
Questionnaire data are based on respondents being asked to select from a list any problems they had during their most 
recent pregnancy, including “high blood sugar (diabetes) that started during this pregnancy.”
a b c
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Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, 
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